HI
ZYNE

Harbour Investments’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Harbour Investments’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-100
Closed -$128 – 3244
2023
Q3 		$128 Hold
100
– – ﹤0.01% 2908
2023
Q2 		$33 Hold
100
– – ﹤0.01% 2993
2023
Q1 		$43 Hold
100
– – ﹤0.01% 2954
2022
Q4 		$53 Hold
100
– – ﹤0.01% 2956
2022
Q3 		$0 Hold
100
– – ﹤0.01% 2875
2022
Q2 		$0 Buy
+100
New +$127 ﹤0.01% 2875
2021
Q4 		$0 Hold
100
– – ﹤0.01% 3882
2021
Q3 		$0 Hold
100
– – ﹤0.01% 4078
2021
Q2 		$1K Hold
100
– – ﹤0.01% 3697
2021
Q1 		$0 Buy
+100
New +$453 ﹤0.01% 3768

Harbour Investments's ZYNE Position: Q4 2023 in Review

Harbour Investments sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q4 2023, closing a stake of 100 shares — an estimated $128 sold.

Harbour Investments first reported a position in ZYNE in Q1 2021 and held it in 10 quarters. The position peaked at $1K in Q2 2021. 0 funds tracked by Wall St. Rank hold ZYNE as of Q4 2023.

  • Harbour Investments reported no remaining Zynerba Pharmaceuticals, Inc position as of Q4 2023 after selling out during the quarter.
  • Harbour Investments sold 100 Zynerba Pharmaceuticals, Inc shares in Q4 2023, an estimated $128.
  • Harbour Investments first reported a position in Zynerba Pharmaceuticals, Inc in Q1 2021 and held it in 10 quarters.
  • Harbour Investments's Zynerba Pharmaceuticals, Inc position peaked at $1K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q4 2023.

Based on Harbour Investments's 13F filing for Q4 2023, filed 16 Feb 2024.